Effects of a pre-visit educational website on information recall and needs fulfilment in breast cancer genetic counselling, a randomized controlled trial by Akke Albada et al.
RESEARCH ARTICLE Open Access
Effects of a pre-visit educational website on
information recall and needs fulfilment in breast
cancer genetic counselling, a randomized
controlled trial
Akke Albada1*, Sandra van Dulmen1,2, Jozien M Bensing1,3 and Margreet GEM Ausems4
Abstract
Introduction: Pre-visit education which helps counselees to prepare for their first visit for breast cancer genetic
counseling might enhance information recall and needs fulfilment. This study assessed the effects of a pre-visit
website with tailored information and question prompt sheet (QPS), named E-info geneca.
Methods: A total of 197 counselees were randomized to receive usual care (UC) or UC plus E-info geneca. All
counselees completed a pre- and post-visit questionnaire and visits were videotaped. We studied effects on
counselees’ information recall, knowledge about breast cancer and heredity, fulfillment of needs, risk perception
alignment, anxiety and perceived personal control, using multilevel regression analyses.
Results: Intent-to-treat analysis showed that counselees in the intervention group (n = 103) had higher levels of
recall of information from the consultation (b = .32; confidence interval (CI): .04 to .60; P = .02; d = .17) and post-
visit knowledge of breast cancer and heredity (b = .30; CI: .03 to .57; P = .03) than counselees in the UC group (n =
94). Also, intervention group counselees reported better fulfilment of information needs (b = .31; CI: .03 to .60; P =
.03). The effects of the intervention were strongest for those counselees who did not receive an indication for DNA
testing. Their recall scores showed a larger increase (b = .95; CI: .32 to 1.59; P = .003; d = .30) and their anxiety
levels dropped more in the intervention compared to the UC group (b = -.60; CI: -1.12 to -.09; P = .02). No
intervention effects were found after the first visit on risk perception alignment or perceived personal control.
Conclusions: This study shows that pre-counseling education, using tailored information technology, leads to
more effective first visits for breast cancer genetic counseling, in particular for counselees who received no
indication for DNA testing and, therefore, had no indication for a second visit. Future study should focus on the
effects of a pre-visit website on the outcomes after a complete series of visits.
Trial registration: Dutch Trial Register ISRCTN82643064.
Introduction
Women who are diagnosed with breast cancer or have
affected relatives often worry about their or their chil-
dren’s risk to (re)develop breast cancer. Therefore, they
might be referred to genetic counseling. Breast cancer
genetic counseling aims to educate individuals about
their breast cancer risk to optimize risk management,
increase personal control and decrease anxiety [1]. How-
ever, studies have consistently found that most counse-
lees still have a marked overestimation of risks relative
to counselors’ evaluations after genetic counseling [2].
The aims of the first visit are mainly to educate the
counselee about breast cancer and genetics, make a risk
estimation and decide whether a DNA test is indicated.
For counselees who are the first in their family to
request breast cancer genetic counseling, an indication
for a DNA test might be for themselves or an affected
relative. These counselees are assigned with the
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transmission of information regarding this possible indi-
cation, breast cancer risks and preventive options to
their relatives. Counselees are unlikely to transfer and
act according to advice that they do not remember [3].
Their recall of information from the first visit is, there-
fore, especially important for the course of breast cancer
genetic counseling and the risk management of them-
selves and their relatives. However, after the initial visit
counselees show only small improvements in knowledge
about breast cancer and genetics [4,5], risk perceptions,
perceived personal control and anxiety [5] and their
recall of information has not been studied yet.
Generally, recall of information from medical visits is
low. Kessels [6] reported that 40% to 80% of the infor-
mation presented was forgotten immediately by patients.
Studies in oncology found that patients recalled only
half of the information provided in general oncology vis-
its when they were cued with topics [7] and actively
reproduced only 23% of the information from consulta-
tions about chemotherapy [3]. Cued recall within
genetic counseling for diverse disorders was higher,
namely three-quarters of the most important items [8].
These higher scores might be due to the percentages of
patients who request genetic counseling at their own
initiative because of a need for information. Alterna-
tively, different ways to assess recall might result in
higher estimates [3].
Unidirectional transfer of generic instead of tailored or
counselee-specific information has long been the pre-
ferred method in cancer genetics, both in the consulta-
tion and in pre-visit information. However, counselee-
specific information is expected to be more effective in
reaching the aims of counseling by increasing the coun-
selee’s recall [9,10]. Tailoring information to individual
needs is an effective way of reducing the amount of
information and ensuring that only relevant information
is provided [11]. According to the Elaboration Likeli-
hood Model and confirmed by findings from neuropsy-
chological research, increased personal relevance of
information enhances central processing [12] and infor-
mation retrieval [13,14]. Therefore, the use of counse-
lee-specific rather than general recommendations should
enhance recall [15]. Additionally, the provision of addi-
tional written information and spreading information
over different time points might show increased reten-
tion [14,16,17]. The combination of pre-visit tailored
information with more counselee-specific information
provided during the visit, might thus result in increased
information recall and knowledge. Additionally,
improved recall of the risk information might increase
the alignment of counselees’ risk perception with the
counselors’ estimation.
Previous studies of computer-based education prior to
genetic counseling were limited to assessment of
counselees’ knowledge about breast cancer and heredity
[18-20]. The current study assessed counselee’s recall of
the counselor’s advice as discussed during the visit.
Comparison with the consultation video determined
whether this recall was correct. As opposed to general
knowledge of hereditary breast cancer this recall of the
counselor’s explanation and advice determines whether
counselees can transfer risk estimates correctly to rela-
tives and can act upon the advice given [7]. Additionally,
fulfillment of information needs evaluates whether the
counselee’s agenda was met. Studies that evaluated the
impact of meeting counselees’ individual needs found
that [21] adjusting communication to these needs
resulted in improved counselee’s perceived personal
control and anxiety [5].
This article describes an randomized controlled trial
(RCT) focused on the effects of a pre-visit educational
website, E-info geneca [22] to optimize the first visit.
The website provided computer-tailored information
concerning counselees’ pre-visit needs, for example, the
procedure and consequences of genetic counseling for
counselees who were the first in their family to request
breast cancer genetic counseling [23]. Additionally, the
website offered a QPS to encourage counselees to for-
mulate questions [24]. These questions were sent ahead
to the counselor and were answered during the visit.
Previous studies showed that after having accessed E-
info geneca, counselees communicated more assertively
by more often sharing their agenda, directing the flow
of the visit and paraphrasing the counselor to check
their understanding. As a result, counselors provided
more counselee-specific information [25]. The current
study evaluates whether the pre-visit educational website
improved counselee outcomes after their first visit, that
is, information recall, knowledge, fulfillment of needs,




This study was conducted at the department of Medical
Genetics of the University Medical Center (UMC)
Utrecht. The study was approved by the institutional
medical ethical committee and is registered in the
Dutch Trial Register (ISRCTN82643064). The depart-
ment of Medical Genetics enrolled counselees from Feb-
ruary 2008 to April 2010. This department offers breast
cancer genetic counseling according to the Dutch guide-
lines [26] and services are similar to those of the other
eight family cancer clinics in the Netherlands. New
counselees, 18 years old or older, who were the first in
their family to seek breast cancer genetic counseling,
were sent information about the study and an opt-out
form. The opt-out form included a question about
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reasons for withdrawal. Counselees were ineligible if
they lacked internet or email access or when they
requested pre-symptomatic DNA testing in the presence
of an identified BRCA1/2 gene mutation in a relative.
All counselees who did not return the opt-out form
were randomly assigned 1:1 to the usual care (UC) or
intervention group (UC + website E-info geneca) by a
secretary unaware of respondent’s characteristics using
sequentially numbered, sealed, opaque envelopes. UC
comprised a brief standard pre-visit leaflet with informa-
tion about the counseling procedure. Both UC and
intervention group respondents received a login to
access the web-based baseline questionnaire. Upon com-
pletion of the baseline questionnaire the intervention
group respondents received a link to access the website
E-info geneca. At the start of the consultation the coun-
selor collected the informed consent form. The visits
were videotaped. In the week after their visit, counselees
again completed a web-based questionnaire. Because
with 100 counselees in each group, there was an 80%
power to detect effect sizes of d = .40 or higher, we
aimed to include 200 counselees.
Counselor characteristics
Counselors were clinical geneticists, residents in clinical
genetics, genetic counselors or genetic counselors in
training. All will be referred to as ‘counselor’. Their age,
gender and number of years of experience with cancer
genetic counseling was assessed at the start of their par-
ticipation in the study.
Counselee characteristics
Age, having children, personal and family cancer history
and educational attainments were assessed in the base-
line counselee questionnaire. All but the latter were
derived from the medical file if missing. Additionally,
whether or not there was an indication for DNA testing
for the counselee or an affected family member was col-
lected from the medical files.
Measures
Counselees’ recall of information from the visit was
assessed in the post-visit questionnaire with seven ques-
tions for cued recall. Each question prompted a topic of
the consultation, for example, limitations of DNA test-
ing and involving family members, and these topics
were based on the counselees’ information needs ques-
tionnaire Quote-geneca [23]. Each question started with
a multiple choice indication of whether the topic was
discussed. Answer options were 1) no, not discussed, 2)
yes it was discussed but I don’t remember what was
said, 3) yes, namely. With the latter, the counselee was
invited to write down what she recalled about this topic
[3].
Coders first assessed whether the topic was discussed
in the visit based on the videotapes. Second, each item
recalled was compared with the specific items men-
tioned by the counselor [3,7]. The percentage of accu-
rate recall was calculated by dividing the sum of the
accurately recalled items by the total number of items
discussed [7].
Recall was coded by AA and a second coder recoded a
random 10% of the visits. Coders were blinded to group
allocation. Interrater reliability was assessed. Cohen’s
kappa for the recall per item averaged 0.70 (range 0.39
to 1.0). The intra class correlation (ICC) of the overall
recall percentage was 0.89.
The level of accurate knowledge about hereditary
breast cancer was assessed using the validated Dutch
hereditary breast cancer knowledge scale [5,27]. Respon-
dents indicated whether each item was correct, incor-
rect, or whether they did not know. A knowledge score
was computed as the mean number of correct answers,
with higher scores indicating more accurate knowledge.
Pre-visit, counselees’ needs were assessed with the
QUality Of counselling Through counselees’ Eyes scale
for cancer genetic counseling (QUOTE-geneca) [23]. At
baseline, respondents indicated the importance (not
important, fairly important, important, extremely impor-
tant) of these needs. Post-visit, identical items were
administered to measure fulfillment of these needs
(inadequate, not really adequate, adequate, more than
adequate) [28]. The QUOTE-geneca includes four gen-
eric needs, which refer to what a counselor should do
during counseling (25 items) and four cancer genetic
information needs, which refer to receiving explanations
on hereditary cancer (19 items), as identified by princi-
pal component analysis with good internal consistency
[23].
Risk perception alignment was defined as the degree
of agreement of the counselee’s risk perception with the
counseled risk [2]. Counselees rated their perceived risk
that they themselves would (re-) develop breast cancer
in the future, that hereditary breast cancer runs in their
family and that they themselves had inherited a breast
cancer gene mutation, on visual analogue scales from 0
to 100%. Counselors rated their estimations of these
risks for the counselee on identical scales after the visit.
Additionally, we categorized this risk based on popula-
tion or slightly increased (< 20%), moderate (17% to
30%) or high risk (> 30%) of developing breast cancer
[29]. The perceived absolute risk of developing breast
cancer was assessed on a 5-point scale from 1 ‘very low
to 5 ‘very high’. Finally, the perceived relative risk was
assessed, indicating whether the counselee perceives her
breast cancer risk as lower, even or higher than the
average risk for women of her age [30].
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Pre- and post-visit anxiety was assessed with the vali-
dated Dutch state version of State-Trait Anxiety Inven-
tory (STAI; 10 items) [28,31]. Scores range from 10 to
40, higher scores indicating greater anxiety.
Pre- and post-visit perceived control was assessed
using the validated Dutch version of the Perceived Per-
sonal Control questionnaire (PPC) [28,32]. Scores range
from 0 to 2 with high scores indicating high perceived
control.
Analysis
We analyzed respondents in the groups to which they
were randomized regardless of whether they actually
accessed E-info geneca or other protocol irregularities.
The few missing values (seven cases) on the baseline
measures of educational attainment were imputed with
the median. Post-visit, the number of missing data on
the outcome variables ranged from 18 for knowledge
and recall, 20 for fulfillment, 22 for perceived personal
control, 25 for anxiety and 43 for risk perception. All
counselees were included in analyses through use of
repeated measures analysis which makes use of available
data of all cases (intention-to-treat analysis) [33].
Intervention and UC group counselees were compared
on socio-demographics, cancer history and levels of pre-
visit measures using Chi-square tests and t-tests. To
account for the multilevel structure of measurements
(level 1) nested within counselees (level 2) nested within
counselors (level 3), random effects multilevel regression
analyses were conducted. This method corrects for the
number of consultations per counselor [34]. The percen-
tage of variance explained at the counselor level ranged
from zero for knowledge to 12% for anxiety. Analyses
were controlled for baseline values, counselee disease sta-
tus, education and receiving an indication for DNA test-
ing. Additionally, analyses were controlled for background
variables at the counselor level, namely whether the coun-
selor was a clinical geneticist or a genetic counselor and
whether or not the counselor was still in training. All ana-
lyses were conducted using Stata 10. Two-sided tests of
significance were performed and results were considered
statistically significant when P < .05. Furthermore, Cohen’s
effect sizes (d) were calculated [35].
Results
Response
Few counselees were ineligible because of lack of inter-
net or email access (24 of 371; 6.5%). The response was
58.6%. Half of the decliners gave a reason (72 of 139;
50.4%). Most decliners preferred that the visit not be
videotaped (48 of 72; 66.7%). There were no significant
differences between participants and decliners in age (t
= 1.62; P = .11), disease status (X2 = .05; P = .81), family
history of cancer (X2 = .06; P = .82) and referral
pathway (X2 = 87; P = .35). A flowchart of the study
and reasons for non-response are shown in Figure 1.
Counselors
All fourteen breast cancer genetic counselors of the
department of Medical Genetics participated and
recorded 4 to 29 consultations each. Six were genetic
counselors, of whom three were in training (all women).
Three were experienced (5 to 15 years) clinical geneti-
cists (two men, one woman) and five were clinical
geneticists in training (all women), see Table 1.
Counselee characteristics
As shown in Table 2 UC and intervention group
respondents were similar with regard to all background
characteristics except for being affected with breast can-
cer themselves (X2 = 5.10; P = .02). There was no signif-
icant association between having (had) breast cancer
and baseline knowledge (T = .12; P = .91). One counse-
lee was affected with ovarian cancer. There were no sig-
nificant baseline differences in knowledge, information
needs, risk perception, anxiety and perceived personal
control between the study groups (Tables 3, 4 and 5).
Information recall
Less than half of all information items were recalled cor-
rectly (Table 6). The total number of recalled items was
significantly higher in the intervention compared to the UC
group (b = .32; CI: .04 to .60; P = .02; d = .17). The effect
size of the intervention was larger for the counselees who
did not receive an indication for DNA testing (b = .95; CI:
.32 to 1.59; P = .003; 52.69(23.72) versus 59.94(25.09); d =
.30). The educational level of the counselee was also a sig-
nificant predictor (b = .59; CI: .32 to .87; P = .000). Addi-
tionally, counselees who were asked to return for a follow-
up consultation recalled less than those who had only one
consultation (b = -.46; CI: -.92 to -.01; P = .046). And
finally, counselees tended to have more recall when they
had seen a genetic counselor (nurse) instead of a clinical
geneticist (b = .27; CI: .00 to .55; P = .047) and less recall
when they had seen a counselor who was still in training (b
= -.29; CI: -.57 to .00; P = .048). This was not related to the
total number of information items discussed (geneticists M
= 7.01 SD = 2.45; counselors M = 6.93 SD = 2.56).
In almost all visits, the counselor provided information
about the probability that hereditary breast cancer runs
in the counselee’s family and of the possibilities and lim-
itations of DNA testing (Table 6). The possibility of risk
reducing breast surgery was significantly more often dis-
cussed in intervention group visits (X2 = 4.81; P = .03).
The probability that hereditary breast cancer runs in the
family was recalled best and information about risk
reducing breast surgery and the emotional consequences
of genetic counseling had the lowest recall scores.
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Knowledge of breast cancer and heredity
Intervention group counselees had relatively more post-
visit knowledge of breast cancer and heredity than UC
group counselees (b = .30; CI: .03 to .57; P = .03; d =
.28). Additionally, counselees in whose family there was
an indication for DNA testing had more post-visit
knowledge (b = .72; CI: .31 to 1.15; P = .001). In the
intervention group, knowledge especially concerning
428 counselees were sent
information about the study
with their appointment letter
336 counselees fulfilled the
inclusion criteria 139 counselees returned opt out
form, told the researcher by
phone they did not wish to
participate or told the
counsellor at the start of the
initial consultation
57 counselees cancelled or
postphoned their appointment
or were counselled at a
community hospital
371 had their appointment
between februari 2008 and
april 2010




Complete data at T1 of 88 counselees
Lost to follow-up (n = 6)
Consultation videotaped (n = 90)
Consultation not videotaped due to
logistic or technical failure (n = 4)
Completed T0 questionnaire (n = 101)
Counselees randomly
assigned (n = 197)
Allocated to website (n = 103) Allocated to UC (n = 94)
Completed T0 questionnaire (n = 89)
Complete data at T1 of 95 counselees
Lost to follow-up (n = 8)
Received allocated intervention (n = 98)
Did not receive allocated intervention
due to technical error (n = 3)
Received allocated intervention, but
viewed only the home page (n = 7)
Received allocated intervention
(n = 89)
Consultation videotaped (n = 102)
Consultation not videotaped due to
technical failure (n = 1)
Analysed (n = 103) Analysed (n = 94)
7 did not want to fill in
questionnaires
67 did not wish to give a
reason
48 did not want to be
videotaped
10 considered the study
too much of a burden
because of their cancer
treatment or psychosocial
situation
2 indicated another reason
5 indicated lack of time as
a reason
7 had a first degree
relative who had attended
breast cancer genetic
counselling
2 were under 18 years
24 did not have internet
access
2 were referred because
of ovarian cancer risk
Figure 1 Flow diagram of study participants.
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inheritance and penetrance of BRCA1/2 mutations was
enhanced (Table 3).
Needs fulfilment
As shown in Table 4 the intervention group counselees
had higher fulfillment scores concerning their cancer
genetic information needs (b = .31; CI: .03 to .60; P =
.03; d = .22). Intervention group counselees especially
indicated higher fulfillment of their need for information
about the determination and meaning of being a carrier
of a mutation in one of the breast cancer genes (b = .29;
CI: .01 to .56; P = .04) and about hereditary breast can-
cer than the UC group counselees (b = .42; CI: .12
to.72; P = .006). Counselees in both groups reported
high fulfillment of generic needs (b = -.18; CI: .36 to
.12; P = .22).
Risk perception
Intervention condition was not associated with the
alignment of the counselee’s perception of her breast
cancer risk with the counselor’s risk estimation (b = .07;
P = .79). Table 5 shows the mean difference between
counselee and counselor’s risk estimation. Neither was
there an intervention effect on the perceived relative
risk or the verbal indication of the height of the risk of
developing breast cancer. Most counselees (101; 67.3%)
overestimated their risk of (re-)developing breast cancer
post-visit. On average their estimation was 21.62 (SD =
17.42) percentage points higher than that of the counse-
lor. A minority of 40 counselees (26.7%) underestimated
their risk with a mean of 10.83 (SD = 8.08) percentage
points. The alignment of counselees’ risk perception
with counselors’ estimation did improve for counselees
who did not receive an indication for DNA testing,
regardless of group allocation. While at baseline 68.8%
Table 1 Characteristics of the genetic counsellors
(N = 14).
Mean SD (range)
Age (years) 36.22 9.60 (26 - 53)
N
Genetic counselor 3
Genetic counselor in training 3
Clinical geneticists 3
Clinical geneticist in training (resident) 5
Male 2
Female 12
Experience in cancer genetic counseling
< 1 year 8
1 to 5 years 1
> 5 years 3
5 to 10 years 0
> 10 years 2





Mean SD (range) Mean SD (range)




N % N %
Children (having children) 64 68.1 71 68.9
Personal history of breast cancer (affected) 29 30.9 49 47.5
1st degree relatives affected with breast cancer 47 52.8 54 52.9
Educational attainment:
University (MSc/BSc)/higher vocational education (BSc) 42 48.8 35 35.34
Middle vocational education 23 26.7 30 30.3
High school/Secondary education 18 20.9 33 33.3
< High school level 3 3.5 1 1.0
Referral pathway:
GP 50 55.6 44 43.1
Specialist consultant UMC 18 24.4 32 31.4
Specialist consultant peripheral hospital 21 20.0 26 25.5
Indication for DNA-testinga 67 71.3 81 78.6
Breast cancer risk category:
High (≥ 30% lifetime risk) 17 18.1 18 17.5
Moderate (20 to 30% lifetime risk) 34 36.2 38 36.9
Population (< 20% lifetime risk) 43 45.8 47 45.6
a Indication for testing the counselee or a relative as judged during the initial visit. Summations vary due to missing values. GP, general practitioner; UC, usual
care; UMC, University Medical Center.
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of counselees overestimated their breast cancer risk
based on the risk categories, this was 32.7% post-visit.
Most counselees (75; 48.7%) also overestimated the
risk of hereditary cancer running in their family, (aver-
age overestimation of 25.68 percentage points (SD =
17.84)) and their risk of being a carrier of a BRCA1/2
mutation (92; 61.3%; average overestimation of 23.46
percentage points (SD = 18.66)). Other counselees
underestimated these risks (69; 45.4%; mean 16.90 (SD
= 13.70) and (52; 34.7%; mean 14.89 (SD = 12.69),
respectively). The alignment of these risk perceptions
with the counselors’ estimations was not significantly
associated with the intervention condition (b = .01; P =
.91 and (b = .07; P = .57, respectively; not shown in
Table).
Anxiety
For the whole group of counselees, post-visit anxiety
was unrelated to the intervention condition (Table 5).
Overall explained variance was 48% and 4% of the var-
iance in the model was due to counselor variation. How-
ever, the group of counselees who did not receive an
Table 3 Counselees’ level of accurate knowledge about breast cancer and heredity.











Scale Mean SD Mean SD Mean SD Mean SD Pa
Accurate knowledge score (0-7) 4.65 1.46 4.64 1.60 5.71 1.53 6.10 1.13 .03








n % n % n % n %
Early detection and treatment of bc lead to longer survival than late detection and
treatment (True)
86 96.6 98 97.0 79 94.1 90 94.7 .74
All women who are carrier of an altered gene (mutation) for bc, will develop bc in
the long term (False)
39 43.8 47 46.5 56 66.7 72 75.8 .048
A woman who has a sister with an altered gene (mutation) for bc, has a 50%
change (1 in 2) to also carry the mutation herself (True)
31 35.2 34 33.7 52 61.9 70 73.7 .09
A woman who does not have an altered gene (mutation) for bc, can nevertheless
develop bc (True)
70 78.7 77 77.8 78 92.9 89 93.7 .74
Physical examination is necessary only when you have complaints; at that point it is
soon enough to prevent bc (False)
84 94.4 93 93.0 76 90.1 89 93.7 .56
If a father has an altered gene (mutation) for bc, then his children have 50%
chance (1 in 2) of also having this mutation (True)
27 30.3 38 37.6 60 71.4 81 85.3 .02
If in a family, in which bc frequently occurs, no altered gene (mutation) for bc is
found, then regular breast surveillance is no longer necessary (False)
77 86.5 82 81.2 79 94.1 88 92.6 .50
a Between group differences at T1. bc, breast cancer; UC, usual care.
Table 4 Counselees’ information needs at baseline and fulfilment of these needs concerning breast cancer genetic
counselling post-visit.









Scale (1-4) Factors (1-4) Mean SD Mean SD Mean SD Mean SD Pa
Cancer genetic information needs 3.24 .38 3.25 .39 3.02 .55 3.14 .53 .03
Determination and meaning of being a carrier of a cancer gene 3.32 .47 3.33 .49 3.03 .62 3.15 .58 .04
Emotional consequences for counselee and family 3.13 .55 3.08 .59 2.88 .69 2.97 .67 .26
Own risk of developing breast cancer 3.44 .47 3.46 .56 2.92 .74 2.99 .77 .36
Heredity of breast cancer 2.67 .53 2.80 .53 3.25 .59 3.44 .53 .008
Generic needs 3.25 .36 3.25 .37 3.21 .44 3.26 .43 .22
Procedural aspects of counseling 2.93 .52 2.82 .58 3.08 .46 3.14 .52 .23
Sensitive communication 2.72 .74 2.65 .79 3.46 .47 3.50 .43 .53
Emotional support 2.93 .53 2.90 .62 3.04 .55 3.06 .49 .46
Assessment of susceptibility 3.09 .54 3.1 .49 3.03 .62 3.12 .59 .17
a Between group differences at T1. UC, usual care.
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indication for DNA testing (n = 49) had significantly
lower anxiety scores in the intervention compared to
the UC group when controlled for baseline values (b =
-.60; CI: -1.12 to -.09; P = .02).
Perceived personal control
Perceived personal control was not significantly related
to the intervention condition (Table 5). Levels tended to
be higher if there was an indication for DNA testing for
Table 5 Effects of E-info geneca on risk perception, anxiety and perceived personal control.










































Breast cancer risk perception alignment (mean difference







16.81 (16.35) .07 .79 .07






















Breast cancer risk perception alignment (mean difference







11.32 (17.59) -.08 .79 .06
a Between group difference at T1. UC, usual care.
Table 6 Counselees’ recall of information items concerning topics discussed in the consultation.













M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) Pa Pb
















M (SD) N (%) ce
topic
discussed
M (SD) Pa Pb
Probability that hereditary breast cancer runs in the family 84 (100) .93 (.30) 91 (97) .90 (.45) .90 .85
Possibilities DNA-test 82 (97) .78 (.46) 88 (95) .80 (.45) .11 .78
Limitations DNA-test 77 (92) .66 (.58) 82 (89) .78 (.67) .50 .09
(the risk of hereditary bc can not be ruled out, testing only
performed on affected individuals, unclassified variant)
Possibilities for early detection of breast cancer 77 (93) 1.00 (.85) 88 (95) .89 (.98) .51 .76
(mammography, MRI, ultrasound, breast self examination, clinical
breast examination of GP/surgeon)
Possibility of risk reducing breast surgery 25 (30) .48 (.51) 43 (46) .68 (.52) .04 .15
Emotional consequences of genetic counselling 47 (57) .73 (.73) 60 (65) .80 (.67) .82 .85
(for the counselee and/or for relatives, for example being reminded
of the illness period, feelings of guilt towards relatives, possibilities
for support)
Involving family members in the genetic counselling procedure 68 (82) 1.01 (.50) 82 (88) .95 (.44) .75 .58
(Asking for permission to request medical file, asking cooperation for
DNA-test, informing about DNA-test)
a Between group differences for items discussed; bBetween group differences for items recalled. bc, breast cancer; ce, counselees; GP, general practitioner; MRI,
magnetic resonance imaging; UC, usual care.
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the counselee or a family member (b = .34; CI: .01 to
.69; P = .06).
Discussion
This study showed that a pre-visit educational website
with QPS improves counselees’ recall of information dis-
cussed in their first visit for breast cancer genetic coun-
seling. As counselees’ transfer of information from the
visit to relatives has been described as a whisper game
where the counselor’s information fades out [36], our
finding of less noise in counselees’ recollection of infor-
mation is very important. Additionally, counselees con-
sidered their need for information better addressed after
the visit. Furthermore, we confirmed previous findings
that pre-visit education improves breast cancer knowl-
edge [18-20]. These findings are in line with the theore-
tical notion that provision of pre-visit information
combined with increased adjustment of information to
the individual increases recall.
In 45-minute first consultations for breast cancer
genetic counseling a large amount of information is
transferred with the intention that the counselee will
understand and remember this information so as to
make decisions about DNA testing and to involve rela-
tives [37,38]. This study is the first to assess how much
counselees actually remember and found that less than
half of the information was recalled. This percentage is
similar to levels of recall in oncology outpatient settings
[7]. The intervention effect on recall was strongest for
those counselees who did not receive an indication for
DNA testing and will therefore not have a second visit.
Although the effect size was modest, other interventions
have failed to produce significant differences [17] or
produced small effect sizes [10]. Future endeavors
should determine ways to further increase recall.
Effects of the intervention on anxiety were only found
for counselees who did not receive an indication for
DNA testing. The lack of improvements for those who
received an indication for DNA testing is understand-
able as the indication itself and waiting for the test
results can be a source of distress [39]. For counselees
who did not receive an indication, their counseling is
limited to one visit and they are generally at population
risk or slightly increased risk. A decrease in their anxiety
is therefore appropriate. Apparently, when counselees
had learned about breast cancer and heredity through
the website they were better able to process the reassur-
ing information in the visit. The computer-tailored
information on the website about indications for heredi-
tary breast cancer and about the need for an indication
for DNA testing might have been helpful to prepare the
counselee for the population risk estimate. This would
result in lower cognitive dissonance during the visit,
which contributes to enhanced processing of
information [40]. Additionally, they might have better
processed the reassuring message because of the slight
increase of counselee-specific information in the first
visit due to the QPS [25]. QPS studies have found
mixed effects on anxiety [10,41]. Possibly, the QPS in
the current study showed effects because the questions
were sent ahead to the counselor and were endorsed by
the counselor.
The pre-visit web-based education had no effect on
alignment of counselees’ risk perceptions with the counse-
lors’ estimation. An explanation for this lack of effect
might be the fact that the risk perception, as opposed to
factual recall of information, seems to be determined to a
large extent by personal experiences of loss [42], identifica-
tion with affected family members and personality factors
[43]. Counselees’ perception of their risk of developing
breast cancer may therefore be less open to change [44].
Additionally, there were no intervention effects on
perceived personal control. Effects of web-based infor-
mation alone might be limited to cognitive outcomes
and might therefore not include perceived personal con-
trol [11,45]. In this study, effects on personal control
were expected through provision of more counselee-spe-
cific information in the visit, but this improvement was
small [25]. Most counselees only receive estimations for
their personal risk in the final visit when the results of
the DNA tests are discussed. Improvements in personal
control might thus be more likely after this final visit as
only after receiving advice for surveillance or preventive
options can counselees take the required actions to con-
trol their risk [32]. Additionally, counselees who did not
receive an indication for DNA testing for themselves did
not gain increased control over decisions. Research on
the effects after the final visit is needed.
Analyses were performed with multilevel analysis to
take differences in counselor styles into account. This
study is the first to show the percentage of variance at
the counselor level and this might provide insight into
the extent to which differences in individual counseling
styles affect genetic counseling outcomes. Although dif-
ferences between counselors have not been studied
before with appropriate methods, several authors have
mentioned the need for this [37,44]. For example,
geneticists and genetic counselors have received differ-
ent training and might have different counseling styles
resulting in better or worse outcomes. Our study
detected a significant difference in the recall of counse-
lees who were counseled by a genetic counselor com-
pared to a clinical geneticist. However, the number of
counselors (14) is too small to guarantee reliable effects
for variables at the counselor level [46]. The variation in
counselors’ communication styles and its impact on out-
comes should be the focus of future multi-center
research allowing for inclusion of more counselors.
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The first visit for breast cancer genetic counseling has
been described as an educational session in which large
amounts of standard information are being transferred
and the counselee’s understanding is scarcely checked
upon [37]. This finding has been reported not only for
the Dutch situation [38], but also for the USA [47,48],
UK [49] and Australia [47,50,51]. Therefore, we expect
that the reported benefits of a pre-visit educational web-
site are generalizable to other countries. However, coun-
tries have different health care systems due to which
populations of breast cancer genetic counselees and
their genetic knowledge might vary slightly [52]. Pre-
visit educational websites should therefore be adapted to
country-specific settings and populations of counselees.
Limitations
There are some limitations. First, counselors were not
blinded to group allocation as they received counselees’
question sheet (QPS) and their responses to these ques-
tions were part of the intervention. Second, the response
rate is moderate, but relatively high for studies using
video recordings of genetic counseling visits [5,38,53].
Importantly, there were no significant differences
between responders and decliners and the results of the
study are therefore representative for breast cancer
genetic counseling counselees. Third, the knowledge
scale showed a clear ceiling effect. On at least two of the
items hardly any improvements from baseline were possi-
ble and this might have hampered the effect size. Fourth,
the high percentage of missing values on counselees’ risk
perception was due to a technical error in the web-based
questionnaire and is therefore unlikely to be related to
counselee characteristics. Fifth, as we have studied the
effects of a combined intervention, we can not distin-
guish between effects of the two components of this web-
based intervention: tailored information and the QPS.
Both the fact that counselees learned from reading infor-
mation on the website and the endorsement of the QPS
in the visit might have contributed to the reported
effects. Sixth, this study lacked power to untangle gender
differences in counselor communication.
Conclusions
When counselees had prepared with a pre-visit website,
they remembered more information from their first con-
sultation for breast cancer genetic counseling and their
information needs were better addressed. If adopted in
practice, pre-counseling education could lead to more
effective first visits for breast cancer genetic counseling
due to improved cognitive outcomes. Counselees who
need to transfer information to their family might better
succeed as a result of increased recall of what was dis-
cussed with the counselor.
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